ホーム>>Lipids>> Glycerophospholipids>>PtdIns-(1,2-dioctanoyl) (sodium salt)

PtdIns-(1,2-dioctanoyl) (sodium salt) (Synonyms: DOPI, Phosphatidylinositol C8)

カタログ番号GC44740

リン酸イノシトール(PtdIns)リン酸脂質は、全体の膜リン脂質のわずかな割合を占めています。

Products are for research use only. Not for human use. We do not sell to patients.

PtdIns-(1,2-dioctanoyl) (sodium salt) 化学構造

Cas No.: 899827-36-2

サイズ 価格 在庫数 個数
100μg
$87.00
在庫あり
500μg
$385.00
在庫あり
1mg
$686.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. PtdIns-(1,2-dioctanoyl) is a synthetic analog of natural phosphatidylinositol (PtdIns) containing C8:0 fatty acids at the sn-1 and sn-2 positions. The compound features the same inositol and diacyl glycerol (DAG) stereochemistry as that of the natural compound. The short fatty acid chains of this analog, compared to naturally-occurring PtdIns, gives it different physical properties including high solubility in aqueous media. PtdIns are phosphorylated to mono- (PtdIns-P; PIP), di- (PtdIns-P2; PIP2), and triphosphates (PtdIns-P3; PIP3). Hydrolysis of PtdIns-(4,5)-P2 by phosphoinositide (PI)-specific phospholipase C generates inositol triphosphate (IP3) and DAG which are key second messengers in an intricate biochemical signal transduction cascade.

レビュー

Review for PtdIns-(1,2-dioctanoyl) (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PtdIns-(1,2-dioctanoyl) (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.